Oral Testosterone Undecanoate Fixed Dosing Without Titration

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing testosterone-based pharmaceutical products require dose titration due to varying absorption and metabolism among patients, making it difficult to achieve safe and efficacious testosterone levels consistently.

Innovation Solution

A fixed daily dose regimen of testosterone undecanoate (TU) ranging from 420-500 mg, administered orally once or twice daily, without titration, effectively maintains safe and efficacious serum testosterone levels in a substantial proportion of patients.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If dose titration is used to accommodate varying absorption and metabolism among patients, then individualized safe and efficacious testosterone levels can be achieved, but treatment complexity and time required for dose adjustment increase

Engineering Contradiction:

Improvetestosterone level safety and efficacyVSAvoiddosing regimen complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent changes the dosage parameter from variable (titration-based) to fixed (standardized), establishing a uniform dosing regimen that eliminates the need for complex dose adjustment while maintaining therapeutic efficacy and safety across diverse patient populations

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent segments the patient population into groups that can be treated with standardized fixed doses, eliminating the need for individualized titration while still accounting for variability through careful dose selection and monitoring protocols

Inventive Principle:

Principle #1Segmentation

2Object-affected harmful factors

If dose titration is implemented to ensure safe testosterone levels, then unacceptably high testosterone concentrations can be avoided, but the time required to reach optimal therapy increases

Engineering Contradiction:

Improveunacceptably high testosterone levelsVSAvoidtime to reach optimal therapy

Core Design Contradiction:

Object-affected harmful factorsVSLoss of time

Solution Approach 1:

The patent performs preliminary optimization of the fixed dose regimen during development to pre-establish safe and effective dosing levels, eliminating the need for time-consuming titration periods while ensuring harmful testosterone levels are avoided from the start of treatment

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent implements monitoring and feedback mechanisms to detect and manage abnormal testosterone levels in real-time, allowing for early intervention without requiring prolonged titration periods to ensure safety

Inventive Principle:

Principle #23Feedback

3Ease of operation

If fixed daily dose is used for oral testosterone undecanoate, then treatment simplicity and patient compliance improve, but variability in absorption and metabolism among patients increases risk of unsafe or suboptimal levels

Engineering Contradiction:

Improvedosing regimen simplicityVSAvoidtestosterone level consistency

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

The patent optimizes the dosage parameter to a specific fixed range that accounts for inter-patient variability in absorption and metabolism, achieving both simplicity and reliability through evidence-based dose selection

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent develops a universal fixed-dose regimen that can be applied across diverse patient populations with varying absorption and metabolism characteristics, eliminating the need for individualized dosing while maintaining consistent therapeutic outcomes

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentEP3544614B1Oral testosterone undecanoate therapy

Publication Date: 2025.12.31 LIPOCINE INC

AI summary

The present disclosure provides methods and compositions for testosterone replacement therapy. The methods and compositions employ a fixed dose dosing regimen that does not require titration or dose adjustments and that can provide a therapeutically effective amount of a testosterone ester while avoiding unacceptably high testosterone levels.